Ignite Creation Date:
2024-07-17 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06498752
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2024-06-20
Brief Title:
MRD-Guided Consolidation Therapy Following Definitive Radiotherapy in Esophageal Cancer
Sponsor:
Cancer Institute and Hospital Chinese Academy of Medical Sciences
Organization:
Cancer Institute and Hospital Chinese Academy of Medical Sciences
Organization Data
Organization:
Cancer Institute and Hospital Chinese Academy of Medical Sciences
Class:
OTHER
Study ID:
BEIR 2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Cancer Institute and Hospital Chinese Academy of Medical Sciences
Lead Sponsor Class:
OTHER
Responsible Party:
Wenyang Liu
Responsible Party Title:
Clinical Associate Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Cancer Institute and Hospital Chinese Academy of Medical Sciences
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Peking University Cancer Hospital Institute | OTHER |
| Hebei Medical University Fourth Hospital | OTHER |
| Tianjin Medical University Cancer Institute and Hospital | OTHER |